H.C WainwrightGlobal Investment Conference and and International Congress of Parkinson’s Disease and Movement Disorders
- Details
- Written by: Developer SM
- Category: Perspectives
- Hits: 15
H.C WainwrightGlobal Investment Conference and and International Congress of Parkinson’s Disease and Movement Disorders
This September Gain Therapeutics is attending and presenting at two conferences.
H.C. Wainwright 26th Annual Global Investment Conference
The H.C. Wainwright 26th Annual Global Investment Conference, taking place from September 9-11, 2024 brings together a mix of institutional investors, corporate executives, and industry experts from sectors such as biotechnology, healthcare, technology, and energy.
Over the past 25 years, the conference has served as a launchpad for countless companies to introduce their cutting-edge technologies and business strategies to a discerning audience.
Key Highlights
- Company Presentations: Get firsthand insights from CEOs and top executives of leading and emerging companies.
- Networking Opportunities: Connect with fellow investors and industry professionals to share strategies and insights.
- Exclusive Meetings: Take advantage of one-on-one meeting opportunities to discuss potential investments in a more intimate setting.
International Congress of Parkinson’s Disease and Movement Disorders
The International Congress of Parkinson’s Disease and Movement Disorders, taking place from September 27-October 1, is one of the most significant events in the field of neurology, bringing together a global community of clinicians, researchers, and healthcare professionals dedicated to advancing the understanding and treatment of movement disorders.
Gain Therapeutics Poster Presentation Details
Gain Therapeutics will be doing several presentations, please see the information below. If you are attending and would like to connect with the team, please connect with:
Abstract Title: The novel glucocerebrosidase chaperone GT-02287 in development for GBA-PD is safe and well tolerated in healthy volunteers at oral doses that produce plasma exposures in the projected therapeutic range
Abstract Number: LBA-10
Abstract Category: Parkinson’s Disease: Clinical Trials
Presentation Date: September 28 – 30 (each day of poster sessions)
Presentation Time: 13:00 – 15:00 ET
Poster Hall: Exhibit Hall A
Gain Therapeutics Oral Presentation Details
Oral Platform Presentation 9: Late-Breaking Abstracts
Date: Sunday, September 29
Time: 13:30-14:30 ET
Agenda Highlights: View the full agenda.
Plenary Sessions: The congress will feature plenary sessions led by renowned experts who will discuss the most recent developments in Parkinson’s disease and movement disorders. These sessions will cover a wide range of topics, including new research findings, emerging therapies, and innovative approaches to patient care.
Scientific Symposia: The symposia will delve into specific aspects of movement disorders, providing attendees with in-depth knowledge and the latest evidence-based practices. Topics will include the genetics of Parkinson’s disease, non-motor symptoms, and the role of neuroimaging in diagnosis and treatment.
Interactive Workshops: Designed to be hands-on and highly engaging, these workshops will offer participants the opportunity to learn from experts in a more intimate setting. Workshops will cover practical aspects of patient care, including the management of complex cases, the use of advanced therapeutic interventions, and rehabilitation techniques.
Poster Sessions: The congress will also feature poster sessions where researchers from around the world will present their latest findings. These sessions provide an opportunity for attendees to engage with cutting-edge research and discuss potential collaborations with fellow participants.
History of the conference:
The International Congress of Parkinson’s Disease and Movement Disorders was first established by the Movement Disorder Society (MDS), a professional society committed to improving patient care through education and research. Since its inception, the congress has grown into a premier event that attracts thousands of participants from around the world.
Over the years, the congress has played a crucial role in shaping the landscape of movement disorder research and treatment. It has provided a platform for the presentation of landmark studies, the unveiling of new therapies, and the discussion of innovative approaches to patient care. The congress has been instrumental in accelerating the translation of research into clinical practice, benefiting patients worldwide.
